85%Confidence
0Views
FDASource
2026-04-12Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates significant contamination issues, which could damage the Taro Pharmaceuticals brand and consumer trust in over-the-counter pediatric medications. This may result in lost sales and increased liability risks for both Strides and Taro.
Actionable: Avoid investments in Strides Pharma and Taro Pharmaceuticals until they demonstrate improved quality control measures for their liquid formulations.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now